Lentivirus-mediated RNAi knockdown of the gap junction protein, Cx43, attenuates the development of vascular restenosis following balloon injury

Han,Xiao-Jian; Chen,Min; Hong,Tao; Zhu,Ling-Yu; He,Dan; Feng,Jiu-Geng; Jiang,Li-Ping

doi:10.3892/ijmm.2015.2078

Lentivirus-mediated RNAi knockdown of the gap junction protein, Cx43, attenuates the development of vascular restenosis following balloon injury

Authors:
- Xiao-Jian Han
- Min Chen
- Tao Hong
- Ling-Yu Zhu
- Dan He
- Jiu-Geng Feng
- Li-Ping Jiang
View Affiliations

Affiliations: Department of Pharmacology, School of Pharmaceutical Science, Nanchang University, Nanchang, Jiangxi 330006, P.R. China, Department of Neurosurgery, The First Affiliated Hospital, Nanchang University, Nanchang, Jiangxi 330006, P.R. China
Published online on: January 23, 2015 https://doi.org/10.3892/ijmm.2015.2078
Pages: 885-892
Copyright: © Han et al. This is an open access article distributed under the terms of Creative Commons Attribution License [CC BY_NC 3.0].

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Percutaneous coronary intervention [PCI or percutaneous transluminal coronary angioplasty (PTCA)] has been developed into a mature interventional treatment for atherosclerotic cardiovascular disease. However, the long-term therapeutic effect is compromised by the high incidence of vascular restenosis following angioplasty, and the underlying mechanisms of vascular restenosis have not yet been fully elucidated. In the present study, we investigated the role of the gap junction (GJ) protein, connexin 43 (Cx43), in the development of vascular restenosis. To establish vascular restenosis, rat carotid arteries were subjected to balloon angioplasty injury. At 0, 7, 14 and 2 days following balloon injury, the arteries were removed, and the intimal/medial area of the vessels was measured to evaluate the degree of restenosis. We found that the intimal area gradually increased following balloon injury. Intimal hyperplasia and restenosis were particularly evident at 14 and 28 days after injury. In addition, the mRNA and protein expression of Cx43 was temporarily decreased at 7 days, and subsequently increased at 14 and 28 days following balloon injury, as shown by RT-PCR and western blot analysis. To determine the involvement of Cx43 in vascular restenosis, the lentivirus vector expressing shRNA targeting Cx43, Cx43-RNAi-LV, was used to silence Cx43 in the rat carotid arteries. The knockdown of Cx43 effectively attenuated the development of intimal hyperplasia and vascular restenosis following balloon injury. Thus, our data indicate the vital role of the GJ protein, Cx43, in the development of vascular restenosis, and provide new insight into the pathogenesis of vascular restenosis. Cx43 may prove to be a novel potential pharmacological target for the prevention of vascular restenosis following PCI.

View Figures

View References

1	Trikalinos TA, Alsheikh-Ali AA, Tatsioni A, Nallamothu BK and Kent DM: Percutaneous coronary interventions for non-acute coronary artery disease: a quantitative 20-year synopsis and a network meta-analysis. Lancet. 373:911–918. 2009. View Article : Google Scholar : PubMed/NCBI
2	Meads C, Cummins C, Jolly K, Stevens A, Burls A and Hyde C: Coronary artery stents in the treatment of ischaemic heart disease: a rapid and systematic review. Health Technol Assess. 4:1–153. 2000.PubMed/NCBI
3	Odell A, Grip L and Hallberg LR: Restenosis after percutaneous coronary intervention (PCI): experiences from the patients’ perspective. Eur J Cardiovasc Nurs. 5:150–157. 2006. View Article : Google Scholar
4	Zhang C, Chaturvedi D, Jaggar L, Magnuson D, Lee JM and Patel TB: Regulation of vascular smooth muscle cell proliferation and migration by human sprouty 2. Arterioscler Thromb Vasc Biol. 25:533–538. 2005. View Article : Google Scholar : PubMed/NCBI
5	Owens GK: Regulation of differentiation of vascular smooth muscle cells. Physiol Rev. 75:487–517. 1995.PubMed/NCBI
6	Crowley ST, Ray CJ, Nawaz D, Majack RA and Horwitz LD: Multiple growth factors are released from mechanically injured vascular smooth muscle cells. Am J Physiol. 269:H1641–H1647. 1995.PubMed/NCBI
7	Li F, Zhang C, Schaefer S, Estes A and Malik KU: ANG II-induced neointimal growth is mediated via cPLA2- and PLD2-activated Akt in balloon-injured rat carotid artery. Am J Physiol Heart Circ Physiol. 289:H2592–H2601. 2005. View Article : Google Scholar : PubMed/NCBI
8	Jia G, Cheng G, Gangahar DM and Agrawal DK: Involvement of connexin 43 in angiotensin II-induced migration and proliferation of saphenous vein smooth muscle cells via the MAPK-AP-1 signaling pathway. J Mol Cell Cardiol. 44:882–890. 2008. View Article : Google Scholar : PubMed/NCBI
9	Hervé JC, Phelan P, Bruzzone R and White TW: Connexins, innexins and pannexins: bridging the communication gap. Biochim Biophys Acta. 1719:3–5. 2005. View Article : Google Scholar : PubMed/NCBI
10	Bruzzone R, White TW and Paul DL: Connections with connexins: the molecular basis of direct intercellular signaling. Eur J Biochem. 238:1–27. 1996. View Article : Google Scholar : PubMed/NCBI
11	Elfgang C, Eckert R, Lichtenberg-Fraté H, et al: Specific permeability and selective formation of gap junction channels in connexin -transfected HeLa cells. J Cell Biol. 129:805–817. 1995. View Article : Google Scholar : PubMed/NCBI
12	van Kempen MJ and Jongsma HJ: Distribution of connexin37, connexin40 and connexin43 in the aorta and coronary artery of several mammals. Histochem Cell Biol. 112:479–486. 1999. View Article : Google Scholar
13	Hong T and Hill CE: Ristricted expression of the gap junctional protein connexin43 in the arterial system of the rat. J Anat. 192:583–593. 1998. View Article : Google Scholar
14	Li X and Simard JM: Increase in Cx45 gap junction channels in cerebral smooth muscle cells from SHR. Hypertension. 40:940–946. 2002. View Article : Google Scholar : PubMed/NCBI
15	Matsushita T, Rama A, Charolidi N, Dupont E and Severs NJ: Relationship of connexin43 expression to phenotypic modulation in cultured human aortic smooth muscle cells. Eur J Cell Biol. 86:617–628. 2007. View Article : Google Scholar : PubMed/NCBI
16	Ram R, Wescott AP, Varandas K, Dirksen RT and Blaxall BC: Mena associates with Rac1 and modulates connexin 43 remodeling in cardiomyocytes. Am J Physiol Heart Circ Physiol. 306:H154–H159. 2014. View Article : Google Scholar :
17	Kieken F, Mutsaers N, Dolmatova E, et al: Structural and molecular mechanisms of gap junction remodeling in epicardial border zone myocytes following myocardial infarction. Circ Res. 104:1103–1112. 2009. View Article : Google Scholar : PubMed/NCBI
18	Qu J, Volpicelli FM, Garcia LI, et al: Gap junction remodeling and spironolactone-dependent reverse remodeling in the hypertrophied heart. Circ Res. 104:365–371. 2009. View Article : Google Scholar :
19	Rucker-Martin C, Milliez P, Tan S, et al: Chronic hemodynamic overload of the atria is an important factor for gap junction remodeling in human and rat hearts. Cardiovasc Res. 72:69–79. 2006. View Article : Google Scholar : PubMed/NCBI
20	Sovari AA, Rutledge CA, Jeong EM, et al: Mitochondria oxidative stress, connexin43 remodeling, and sudden arrhythmic death. Circ Arrhythm Electrophysiol. 6:623–631. 2013. View Article : Google Scholar : PubMed/NCBI
21	Meng QH, Yang G, Yang W, Jiang B, Wu L and Wang R: Protective effect of hydrogen sulfide on balloon injury-induced neointima hyperplasia in rat carotid arteries. Am J Pathol. 170:1406–1414. 2007. View Article : Google Scholar : PubMed/NCBI
22	Ai Z, Yin L, Zhou X, et al: Inhibition of survivin reduces cell proliferation and induces apoptosis in human endometrial cancer. Cancer. 107:746–756. 2006. View Article : Google Scholar : PubMed/NCBI
23	Barac YD, Zeevi-Levin N, Yaniv G, et al: The 1,4,5-inositol trisphosphate pathway is a key component in Fas-mediated hypertrophy in neonatal rat ventricular myocytes. Cardiovasc Res. 68:75–86. 2005. View Article : Google Scholar : PubMed/NCBI
24	Chadjichristos CE, Morel S, Derouette JP, et al: Targeting connexin 43 prevents platelet-derived growth factor-BB-induced phenotypic change in porcine coronary artery smooth muscle cells. Circ Res. 102:653–660. 2008. View Article : Google Scholar : PubMed/NCBI
25	Severs NJ, Rothery S, Dupont E, et al: Immunocytochemical analysis of connexin expression in the healthy and diseased cardiovascular system. Microsc Res Tech. 52:301–322. 2001. View Article : Google Scholar : PubMed/NCBI
26	Brisset AC, Isakson BE and Kwak BR: Connexins in vascular physiology and pathology. Antioxid Redox Signal. 11:267–282. 2009. View Article : Google Scholar
27	Chadjichristos CE, Matter CM, Roth I, et al: Reduced connexin43 expression limits neointima formation after balloon distension injury in hypercholesterolemic mice. Circulation. 113:2835–2843. 2006. View Article : Google Scholar : PubMed/NCBI
28	Wang L, Chen J, Sun Y, et al: Regulation of connexin expression after balloon injury: possible mechanisms for antiproliferative effect of statins. Am J Hypertens. 18:1146–1153. 2005. View Article : Google Scholar : PubMed/NCBI
29	Wang LH, Chen JZ, Sun YL, et al: Statins reduce connexin40 and connexin43 expression in atherosclerotic aorta of rabbits. Int J Cardiol. 100:467–475. 2005. View Article : Google Scholar : PubMed/NCBI